DRC to launch first phase of Mpox vaccination campaign amid ongoing outbreak
13 oC
13 oC
Güneşli
13 oC
Güneşli
The Democratic Republic of the Congo (DRC), the "epicenter" of Africa's ongoing Mpox outbreak, will begin the first phase of its vaccination campaign on October 2, the government announced.
The campaign, which will run until October 11, follows the receipt of over 265,000 vaccine doses from international partners.
The DRC has reported 21,813 suspected cases of Mpox, with 716 deaths recorded since the beginning of 2024, according to a report released Friday by the Congolese Ministry of Health. The country is responsible for approximately 90 percent of Mpox cases across Africa.
The vaccination campaign comes as the World Health Organization (WHO) approved the MVA-BN vaccine, developed by Bavarian Nordic, for its prequalification list, marking it as the first officially approved vaccine for Mpox. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
The UK’s National Health Service (NHS) is set to pilot an AI-driven “one-day diagnostics” service for prostate cancer that could revolutionize early detection and dramatically cut waiting times for thousands of men each year.
The health situation in the Gaza Strip has reached a catastrophic level, with more than 70,000 hepatitis cases reported across the besieged enclave, according to health authorities.
The Polio Free Afghanistan Foundation announced that a polio vaccination drive will begin tomorrow in the eastern provinces of Kunar, Nuristan, and Laghman.
Prof. Dr. Engin Yıldırım, an Obstetrics and Gynecology specialist at Malatya Training and Research Hospital and faculty member at Malatya Turgut Özal University, has called for greater public awareness about the benefits of natural childbirth.
